	Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer. Clin Cancer Res Dieci MV, Gasparini E, Nicolè L, Schmid P, Zambelli A, Favaretto A, Piacentini F, Bianchi GV, Mion M, Ferro A, Arpino G, Emiliani A, Cinieri S, Zamagni C, Gennari A, Spazzapan S, Sartori D, Zustovich F, Tamberi S, Del Mastro L, De Laurentiis M, Musolino A, Cagossi K, Generali D, Giarratano T, Giovanardi F, De Salvo GL, Conte P, Guarneri V. PMID: 42467210 [PubMed - as supplied by publisher]
	Patterns of Care and Follow-up of Patients with an Ipsilateral Breast Tumor Event After Breast-Conserving Surgery: A Multicenter Retrospective Cohort Study in the Netherlands. Ann Surg Oncol Wurfbain LF, Tiels LM, van der Sangen MJC, Walstra CJEF, van Maaren MC, Vriens BEPJ, van Oordt CWMH, Bloemen JG, Voogd AC, Nieuwenhuijzen GAP, van den Bongard DHJG, Schipper RJ, Dutch Snapshot Research Group. PMID: 42467154 [PubMed - as supplied by publisher]
	Impact of Neoadjuvant Immunochemotherapy on Surgical Outcomes in Management of Early Triple-Negative Breast Cancer. Breast J Khadrouche T, Morisseau M, Selmes G, Vaysse C, Franchet C, Massabeau C, Ung M, Maio E, Lacaze JL, Jouve E. PMID: 42467061 [PubMed - indexed for MEDLINE]
	Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs. Expert Opin Emerg Drugs Ottum S, Sethi N, Demirkiran C, De Tommasi O, Santin AD. PMID: 42466859 [PubMed - as supplied by publisher]
	Incidence, Trends, and Racial/Ethnic Disparities in Female Breast Cancer in the United States, 2000-2023: A SEER Based Study. Cancer Control Mzizi NO, Ndabezitha SS, Atta JA, Al Zoubi MA, Akkala S. PMID: 42466659 [PubMed - in process]
	Integrative analysis using Mendelian randomization and network toxicology reveals genetic support and potential mechanisms of atrazine in breast cancer. Int J Gynaecol Obstet Zhao Z, Cai Y, Li C, Du C, Zhang S. PMID: 42466619 [PubMed - as supplied by publisher]
	Advancements in Nanoparticle-Based Therapies for Breast Cancer: Current Trends and Future Prospects. Int J Breast Cancer Matalqah SM, Matalqah LM, Al Tawaha AR, Karnwal A, Radaideh L, Mhaidat A, Nesterova N. PMID: 42466316 [PubMed]
	Distribution characteristics and associated factors of dyslipidemia across clinical stages of breast cancer: a retrospective observational study. Front Glob Womens Health Xin Z, Qu H, Li P, Han Z, Qu N, Yu W, Zhu X, Chen H. PMID: 42466022 [PubMed]
	Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study. Front Med (Lausanne) Wei B, Fu Z, Shao Y, Sun X, Chen L. PMID: 42465101 [PubMed]
	PARP inhibitor maintenance in first-line ovarian cancer therapy: emerging standards and strategies to overcome resistance. Am J Cancer Res Chen H. PMID: 42465024 [PubMed]
	Advances in ferroptosis research in ovarian cancer: molecular mechanisms and therapeutic perspectives. Am J Cancer Res Han Y, Shen X, Wang K, Li L, Yang Y, Suhaimi SA, Wei Y, Zhang W, Sun K, Li Z, Zhang H, Sandai D, He Y. PMID: 42465023 [PubMed]
	"Microneedles in breast cancer therapy: navigating treatment innovation amid biological and technological challenges". Ther Deliv Pachipala M, Ruby JJ, Puttegowda VD. PMID: 42464738 [PubMed - as supplied by publisher]
	Breast cancer radiotherapy in patients with autoimmune or cancer-associated myositis: balancing oncological benefit and immune-mediated risk. Radiat Oncol Falivene S, Mercogliano S, Bertolini N, Costa L, Cascone M, Esposito E, Ferraioli P, Mottareale R, Ravo V, Caso F. PMID: 42464399 [PubMed - as supplied by publisher]
	Effects of highâ€‘intensity interval training on physical function and quality of life in breast cancer patients: a systematic review and meta-analysis. BMC Sports Sci Med Rehabil Zheng J, Yan R, Zhou S, Lin J. PMID: 42464337 [PubMed - as supplied by publisher]
	Enhancing ultrasound training for breast cancer diagnosis: a controlled study of AI-assisted learning. BMC Med Educ Wu S, Wang W, Wu J, Zhou H, Gong X, Liu Y, Zhou Y. PMID: 42464241 [PubMed - as supplied by publisher]
	Black women's decisions about participating in breast cancer screening in the UK: a qualitative study. Br J Cancer Aliu AE, Kerrison RS, Marcu A. PMID: 42463963 [PubMed - as supplied by publisher]
	A Noise-Aware Robustness Evaluation Framework for Breast Cancer Classification in Ultrasound Imaging. J Imaging Inform Med Arriz-Jorquiera M, Bakht A, Uysal I, Del Toro MH, Lai-Yuen S, Zayas-Castro JL. PMID: 42463622 [PubMed - as supplied by publisher]
	A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci SP(Â®) Surgical System versus Open Surgery in Nipple-Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer. Ann Surg Oncol Kopkash K, Piltin M, Jakub J, Javid S, Flanagan MR, Aft R, Chiba A, Lal A, Brooks AD, Amersi F, Dekhne N, Tseng J, Farley C, Kadison A, Johnson J, Hwang RF. PMID: 42463607 [PubMed - as supplied by publisher]
	An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer. Discov Oncol Zhang X, Cao M, Wu L, Zhao Y. PMID: 42463566 [PubMed - as supplied by publisher]
	Value of Axillary Palpation and Ultrasound, and Axillary Recurrence in Male Breast Cancer: Results of the Registry Study. Int J Cancer Graeser M, Bothin S, Gluz O, Warm M, Ignatov A, Eggemann H. PMID: 42463458 [PubMed - as supplied by publisher]

Articles 1 - 20 / 332312

Page 1 of 16616



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy